Moderate to Severe COPD Study
Ages
Study Topic
Compensation
COPD Trials in Columbus
Centricity Research is currently participating in a clinical trial for Chronic Obstructive Pulmonary Disease (COPD) at our Dublin, Ohio location to discover advances in medical knowledge and treatment for the disease. As one of the most prominent disabilities in the United States, COPD is the third leading cause of death according to the National Heart, Lung and Blood Institute. There is no current cure, making clinical trials crucial to lead the development in finding possible treatments.
Moderate to Severe COPD Study Now Enrolling
The primary objective of this clinical trial is to evaluate measured dose inhalers (MDIs) containing a fixed-dose triple combination of FDA approved drugs that utilize either a current FDA approved propellant or an investigational propellant that has a lower global warming potential. You may qualify for this study if you are:
- Ages 40-80
- A former or current smoker who has been diagnosed with COPD
AND
- Have been regularly using dual ICS/LABA, LAMA/LABA, or ICS/LAMA/LABA (open or fixed-dose combinations) inhaled maintenance therapies for COPD management for at least 6 weeks prior to screening
Ready to Volunteer?
Volunteer today to see if you qualify for our moderate to severe COPD clinical research study. Qualified volunteers may be compensated for time and travel.